OrbiMed

OrbiMed executes multiple investment strategies, including private equity for startups, public equity for traded entities, and private credit for commercial-stage companies. It offers structured debt and royalty monetization as non-dilutive financing solutions for owners of intellectual property and medical diagnostics. The firm manages a global portfolio that supports the development of new therapies, medical devices, and healthcare information technology systems.